Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
Submitted Feb 08 2011 10:22 AM
Nonmelanoma skin cancer is one of the most common malignancies in humans. Different therapeutic strategies for the treatment of these tumors are currently being investigated. Given thegrowth-inhibiting effects of cannabinoids on gliomas and the wide tissue distribution of the two subtypes of cannabinoid receptors (CB1and CB2), we studied the potential utility of these compounds in antiâ€“skin tumor therapy.